| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Altered immunity to microbiota, B cell activation and depleted γδ/resident memory T cells in colorectal cancer
|
Noble, Alistair
|
|
|
71 |
11 |
p. 2619-2629
|
artikel
|
| 2 |
Camrelizumab combined with apatinib and S-1 as second-line treatment for patients with advanced gastric or gastroesophageal junction adenocarcinoma: a phase 2, single-arm, prospective study
|
Jing, Chao
|
|
|
71 |
11 |
p. 2597-2608
|
artikel
|
| 3 |
Chimeric antigen receptor clustering via cysteines enhances T-cell efficacy against tumor
|
Wang, Yuedi
|
|
|
71 |
11 |
p. 2801-2814
|
artikel
|
| 4 |
Clinical and molecular correlates of response to immune checkpoint blockade in urothelial carcinoma with liver metastasis
|
Yoshida, Takashi
|
|
|
71 |
11 |
p. 2815-2828
|
artikel
|
| 5 |
Correction to: Functional antigen processing and presentation mechanism as a prerequisite factor of response to treatment with dendritic cell vaccines and anti-PD-1 in preclinical murine LLC1 and GL261 tumor models
|
Žilionytė, Karolina
|
|
|
71 |
11 |
p. 2701
|
artikel
|
| 6 |
CXCL9-modified CAR T cells improve immune cell infiltration and antitumor efficacy
|
Tian, Yonggui
|
|
|
71 |
11 |
p. 2663-2675
|
artikel
|
| 7 |
Epstein-Barr virus-induced ectopic CD137 expression helps nasopharyngeal carcinoma to escape immune surveillance and enables targeting by chimeric antigen receptors
|
Prasad, Mukul
|
|
|
71 |
11 |
p. 2583-2596
|
artikel
|
| 8 |
Establishment of a mechanism-based in vitro coculture assay for evaluating the efficacy of immune checkpoint inhibitors
|
Kim, Myeong Joon
|
|
|
71 |
11 |
p. 2777-2789
|
artikel
|
| 9 |
Evaluation of the efficacy and safety of TAS0313 in adults with recurrent glioblastoma
|
Narita, Yoshitaka
|
|
|
71 |
11 |
p. 2703-2715
|
artikel
|
| 10 |
Evolution of bone metastases in patients receiving at least three months of checkpoint inhibitors
|
Gefard-Gontier, E.
|
|
|
71 |
11 |
p. 2609-2618
|
artikel
|
| 11 |
Functional antigen processing and presentation mechanism as a prerequisite factor of response to treatment with dendritic cell vaccines and anti-PD-1 in preclinical murine LLC1 and GL261 tumor models
|
Žilionytė, Karolina
|
|
|
71 |
11 |
p. 2691-2700
|
artikel
|
| 12 |
Gene expression profile of high PD-L1 non-small cell lung cancers refractory to pembrolizumab
|
Talb, Jamila
|
|
|
71 |
11 |
p. 2791-2799
|
artikel
|
| 13 |
Lenvatinib plus pembrolizumab for systemic therapy-naïve and -experienced unresectable hepatocellular carcinoma
|
Wu, Chi-Jung
|
|
|
71 |
11 |
p. 2631-2643
|
artikel
|
| 14 |
OIT3 mediates macrophage polarization and facilitates hepatocellular carcinoma progression
|
Yang, Shuai
|
|
|
71 |
11 |
p. 2677-2689
|
artikel
|
| 15 |
Prognostic significance of NY-ESO-1 antigen and PIGR expression in esophageal tumors of CHP-NY-ESO-1-vaccinated patients as adjuvant therapy
|
Nagata, Yasuhiro
|
|
|
71 |
11 |
p. 2743-2755
|
artikel
|
| 16 |
Role of the cGAS-STING pathway in regulating the tumor-immune microenvironment in dMMR/MSI colorectal cancer
|
Kaneta, Akinao
|
|
|
71 |
11 |
p. 2765-2776
|
artikel
|
| 17 |
Serial interferon-gamma release assay in lung cancer patients receiving immune checkpoint inhibitors: a prospective cohort study
|
Fujita, Kohei
|
|
|
71 |
11 |
p. 2757-2764
|
artikel
|
| 18 |
Tafasitamab mediates killing of B-cell non-Hodgkin’s lymphoma in combination with γδ T cell or allogeneic NK cell therapy
|
Her, Jung Hyun
|
|
|
71 |
11 |
p. 2829-2836
|
artikel
|
| 19 |
The expression of PD-1 ligand 1 on macrophages and its clinical impacts and mechanisms in lung adenocarcinoma
|
Shinchi, Yusuke
|
|
|
71 |
11 |
p. 2645-2661
|
artikel
|
| 20 |
The soluble form of CD160 acts as a tumor mediator of immune escape in melanoma
|
Gauci, Marie-Léa
|
|
|
71 |
11 |
p. 2731-2742
|
artikel
|
| 21 |
Tumor-derived exosomes drive pre-metastatic niche formation in lung via modulating CCL1+ fibroblast and CCR8+ Treg cell interactions
|
Wang, Ming
|
|
|
71 |
11 |
p. 2717-2730
|
artikel
|
Tijdschrift beschrijving